earnings
RO
NASDAQ · ROIV
Roivant Sciences Ltd.
Healthcare · Biotechnology
$37.37
Up+$1.13 (+3.12%)
Updated Aug 19, 2026, 9:29 AM
SID Score
7.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 14.83B
- P/E ratio
- -38.83
- Dividend yield
- 0.00%
- 52-week range
- $11.60 – $37.46
- Volume
- 6.41M
- Avg. volume
- 8.16M
Price performance
ROIV price history
1M range · 21 trading sessions · Daily adjusted prices
ROIV closed at $37.37 after 21 trading sessions, up 6.89% for the selected period.
- Last close
- $37.37
- Period change
- +6.89%
- Period low
- $32.87
- Period high
- $37.37
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $35.91 | $37.46 | $35.86 | $37.37 | 6.41M |
| Aug 17, 2026 | $36.22 | $37.19 | $35.65 | $36.24 | 7.73M |
| Aug 14, 2026 | $36.135 | $36.49 | $35.87 | $36.20 | 4.53M |
| Aug 13, 2026 | $36.70 | $36.70 | $35.78 | $36.28 | 6.03M |
| Aug 12, 2026 | $35.22 | $36.50 | $35.22 | $36.16 | 4.99M |
| Aug 11, 2026 | $36.00 | $36.00 | $34.56 | $35.25 | 5.84M |
| Aug 10, 2026 | $36.05 | $36.78 | $35.68 | $35.78 | 7.94M |
| Aug 7, 2026 | $35.88 | $36.44 | $35.62 | $36.34 | 6.74M |
| Aug 6, 2026 | $33.11 | $35.37 | $33.11 | $35.12 | 8.25M |
| Aug 5, 2026 | $34.89 | $35.56 | $34.35 | $34.60 | 5.86M |
| Aug 4, 2026 | $33.74 | $34.70 | $33.45 | $34.59 | 5.88M |
| Aug 3, 2026 | $33.225 | $33.43 | $32.47 | $33.32 | 5.99M |
| Jul 31, 2026 | $34.275 | $34.50 | $33.54 | $33.91 | 5.4M |
| Jul 30, 2026 | $33.39 | $34.54 | $33.01 | $34.52 | 4.56M |
| Jul 29, 2026 | $33.85 | $34.30 | $32.83 | $32.87 | 4.82M |
| Jul 28, 2026 | $34.62 | $34.83 | $33.50 | $33.84 | 4.4M |
| Jul 27, 2026 | $35.13 | $35.58 | $34.59 | $34.72 | 4.27M |
| Jul 24, 2026 | $35.23 | $35.59 | $34.795 | $35.01 | 4.04M |
| Jul 23, 2026 | $34.46 | $35.695 | $34.14 | $35.10 | 4.25M |
| Jul 22, 2026 | $34.65 | $35.13 | $34.55 | $34.91 | 3.4M |
| Jul 21, 2026 | $34.14 | $35.24 | $34.02 | $34.96 | 4.73M |
Latest ROIV news
The latest Smart Investors Daily articles mentioning ROIV.
Stock researchResearch & News · Competitors
Loading stock research…